Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy.
Meuleman MS, Petitprez F, Pickering MC, Le Quintrec M, Artero MR, Duval A, Rabant M, Gilmore A, Boyer O, Hogan J, Servais A, Provot F, Gnemmi V, Eloudzeri M, Grunenwald A, Buob D, Boffa JJ, Moktefi A, Audard V, Goujon JM, Bridoux F, Thervet E, Karras A, Roumenina LT, Frémeaux Bacchi V, Duong Van Huyen JP, Chauvet S. Meuleman MS, et al. Among authors: fremeaux bacchi v. J Am Soc Nephrol. 2024 Aug 1;35(8):1034-1044. doi: 10.1681/ASN.0000000000000373. Epub 2024 May 6. J Am Soc Nephrol. 2024. PMID: 38709564
Functional Characterization of Anti-C3bBb Autoantibodies and C3 Glomerulopathy Phenotype.
Roquigny J, Meuleman MS, El Sissy C, Cailliez M, Servais A, Roussey G, Baudouin V, Decramer S, Nobili F, Wynckel A, Sellier Leclerc AL, Lapeyraque AL, Martins PV, Meri S, Dragon-Durey MA, Chauvet S, Frémeaux-Bacchi V. Roquigny J, et al. Among authors: fremeaux bacchi v. J Am Soc Nephrol. 2024 Sep 26. doi: 10.1681/ASN.0000000000000499. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39325562 No abstract available.
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.
Nester C, Decker DA, Meier M, Aslam S, Bomback AS, Caravaca-Fontán F, Cook TH, Feldman DL, Fremeaux-Bacchi V, Gale DP, Gooch A, Johnson S, Licht C, Mathur M, Pickering MC, Praga M, Remuzzi G, Selvarajah V, Smith RJ, Tabriziani H, van de Kar N, Wang Y, Wong E, Mistry K, Lim M, Portillo C, Balogun S, Trachtman H, Thompson A. Nester C, et al. Among authors: fremeaux bacchi v. Clin J Am Soc Nephrol. 2024 Jun 3;19(9):1201-8. doi: 10.2215/CJN.0000000000000505. Online ahead of print. Clin J Am Soc Nephrol. 2024. PMID: 38829708
353 results